(Q72079776)
Statements
Effects of administration of an anti-CD5 plus immunoconjugate in rheumatoid arthritis. Results of two phase II studies. The CD5 Plus Rheumatoid Arthritis Investigators Group (English)
V Strand
P E Lipsky
G W Cannon
L H Calabrese
C Wiesenhutter
S B Cohen
N J Olsen
M L Lee
T J Lorenz